Cargando…
Moving toward a contemporary classification of drug-induced kidney disease
Drug-induced kidney disease (DIKD) accounts for about one-fourth of all cases of acute kidney injury (AKI) in hospitalized patients, especially in critically ill setting. There is no standard definition or classification system of DIKD. To address this, a phenotype definition of DIKD using expert co...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10633929/ https://www.ncbi.nlm.nih.gov/pubmed/37946280 http://dx.doi.org/10.1186/s13054-023-04720-2 |
_version_ | 1785132718072266752 |
---|---|
author | Karimzadeh, Iman Barreto, Erin F. Kellum, John A. Awdishu, Linda Murray, Patrick T. Ostermann, Marlies Bihorac, Azra Mehta, Ravindra L. Goldstein, Stuart L. Kashani, Kianoush B. Kane-Gill, Sandra L. |
author_facet | Karimzadeh, Iman Barreto, Erin F. Kellum, John A. Awdishu, Linda Murray, Patrick T. Ostermann, Marlies Bihorac, Azra Mehta, Ravindra L. Goldstein, Stuart L. Kashani, Kianoush B. Kane-Gill, Sandra L. |
author_sort | Karimzadeh, Iman |
collection | PubMed |
description | Drug-induced kidney disease (DIKD) accounts for about one-fourth of all cases of acute kidney injury (AKI) in hospitalized patients, especially in critically ill setting. There is no standard definition or classification system of DIKD. To address this, a phenotype definition of DIKD using expert consensus was introduced in 2015. Recently, a novel framework for DIKD classification was proposed that incorporated functional change and tissue damage biomarkers. Medications were stratified into four categories, including “dysfunction without damage,” “damage without dysfunction,” “both dysfunction and damage,” and “neither dysfunction nor damage” using this novel framework along with predominant mechanism(s) of nephrotoxicity for drugs and drug classes. Here, we briefly describe mechanisms and provide examples of drugs/drug classes related to the categories in the proposed framework. In addition, the possible movement of a patient’s kidney disease between certain categories in specific conditions is considered. Finally, opportunities and barriers to adoption of this framework for DIKD classification in real clinical practice are discussed. This new classification system allows congruencies for DIKD with the proposed categorization of AKI, offering clarity as well as consistency for clinicians and researchers. |
format | Online Article Text |
id | pubmed-10633929 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-106339292023-11-10 Moving toward a contemporary classification of drug-induced kidney disease Karimzadeh, Iman Barreto, Erin F. Kellum, John A. Awdishu, Linda Murray, Patrick T. Ostermann, Marlies Bihorac, Azra Mehta, Ravindra L. Goldstein, Stuart L. Kashani, Kianoush B. Kane-Gill, Sandra L. Crit Care Perspective Drug-induced kidney disease (DIKD) accounts for about one-fourth of all cases of acute kidney injury (AKI) in hospitalized patients, especially in critically ill setting. There is no standard definition or classification system of DIKD. To address this, a phenotype definition of DIKD using expert consensus was introduced in 2015. Recently, a novel framework for DIKD classification was proposed that incorporated functional change and tissue damage biomarkers. Medications were stratified into four categories, including “dysfunction without damage,” “damage without dysfunction,” “both dysfunction and damage,” and “neither dysfunction nor damage” using this novel framework along with predominant mechanism(s) of nephrotoxicity for drugs and drug classes. Here, we briefly describe mechanisms and provide examples of drugs/drug classes related to the categories in the proposed framework. In addition, the possible movement of a patient’s kidney disease between certain categories in specific conditions is considered. Finally, opportunities and barriers to adoption of this framework for DIKD classification in real clinical practice are discussed. This new classification system allows congruencies for DIKD with the proposed categorization of AKI, offering clarity as well as consistency for clinicians and researchers. BioMed Central 2023-11-09 /pmc/articles/PMC10633929/ /pubmed/37946280 http://dx.doi.org/10.1186/s13054-023-04720-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Perspective Karimzadeh, Iman Barreto, Erin F. Kellum, John A. Awdishu, Linda Murray, Patrick T. Ostermann, Marlies Bihorac, Azra Mehta, Ravindra L. Goldstein, Stuart L. Kashani, Kianoush B. Kane-Gill, Sandra L. Moving toward a contemporary classification of drug-induced kidney disease |
title | Moving toward a contemporary classification of drug-induced kidney disease |
title_full | Moving toward a contemporary classification of drug-induced kidney disease |
title_fullStr | Moving toward a contemporary classification of drug-induced kidney disease |
title_full_unstemmed | Moving toward a contemporary classification of drug-induced kidney disease |
title_short | Moving toward a contemporary classification of drug-induced kidney disease |
title_sort | moving toward a contemporary classification of drug-induced kidney disease |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10633929/ https://www.ncbi.nlm.nih.gov/pubmed/37946280 http://dx.doi.org/10.1186/s13054-023-04720-2 |
work_keys_str_mv | AT karimzadehiman movingtowardacontemporaryclassificationofdruginducedkidneydisease AT barretoerinf movingtowardacontemporaryclassificationofdruginducedkidneydisease AT kellumjohna movingtowardacontemporaryclassificationofdruginducedkidneydisease AT awdishulinda movingtowardacontemporaryclassificationofdruginducedkidneydisease AT murraypatrickt movingtowardacontemporaryclassificationofdruginducedkidneydisease AT ostermannmarlies movingtowardacontemporaryclassificationofdruginducedkidneydisease AT bihoracazra movingtowardacontemporaryclassificationofdruginducedkidneydisease AT mehtaravindral movingtowardacontemporaryclassificationofdruginducedkidneydisease AT goldsteinstuartl movingtowardacontemporaryclassificationofdruginducedkidneydisease AT kashanikianoushb movingtowardacontemporaryclassificationofdruginducedkidneydisease AT kanegillsandral movingtowardacontemporaryclassificationofdruginducedkidneydisease |